Search research articles
Contact Us
Filters
Showing results (431-440 of 436) with videos related to
Page
of 44
Sort By:
You have reached the last page of results.
This site can display upto 436 results.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
June 28, 2018
Efficacy and Safety of Intravenous Tenecteplase Bolus in Acute Ischemic Stroke: Results of Two Open-Label, Multicenter Trials
Tirppur C R Ramakrishnan, Somasundaram Kumaravelu, Sunil K Narayan, et al.
Eclinicalmedicine
|
December 6, 2021
A phase 2/3, participant-blind, observer-blind, randomised, controlled study to assess the safety and immunogenicity of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) in adults in India
Prasad S Kulkarni, Chandrasekaran Padmapriyadarsini, Johan Vekemans, et al.
Human Vaccines & Immunotherapeutics
|
March 21, 2024
Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adults
Prasad S Kulkarni, Chandrasekaran Padmapriyadarsini, Johan Vekemans, et al.
Rhinology
|
July 16, 2023
Position paper on olfactory dysfunction: 2023
K L Whitcroft, A Altundag, P Balungwe, et al.
International Forum of Allergy & Rhinology
|
February 19, 2016
International Consensus Statement on Allergy and Rhinology: Rhinosinusitis
Richard R Orlandi, Todd T Kingdom, Peter H Hwang, et al.
International Forum of Allergy & Rhinology
|
November 25, 2020
International consensus statement on allergy and rhinology: rhinosinusitis 2021
Richard R Orlandi, Todd T Kingdom, Timothy L Smith, et al.
Page
of 44
Search research articles
Search
Showing results (431-440 of 436) with videos related to
Sort By:
Page
of 44
You have reached the last page of results.
This site can display upto 436 results.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
June 28, 2018
Efficacy and Safety of Intravenous Tenecteplase Bolus in Acute Ischemic Stroke: Results of Two Open-Label, Multicenter Trials
Tirppur C R Ramakrishnan, Somasundaram Kumaravelu, Sunil K Narayan, et al.
Eclinicalmedicine
|
December 6, 2021
A phase 2/3, participant-blind, observer-blind, randomised, controlled study to assess the safety and immunogenicity of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) in adults in India
Prasad S Kulkarni, Chandrasekaran Padmapriyadarsini, Johan Vekemans, et al.
Human Vaccines & Immunotherapeutics
|
March 21, 2024
Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adults
Prasad S Kulkarni, Chandrasekaran Padmapriyadarsini, Johan Vekemans, et al.
Rhinology
|
July 16, 2023
Position paper on olfactory dysfunction: 2023
K L Whitcroft, A Altundag, P Balungwe, et al.
International Forum of Allergy & Rhinology
|
February 19, 2016
International Consensus Statement on Allergy and Rhinology: Rhinosinusitis
Richard R Orlandi, Todd T Kingdom, Peter H Hwang, et al.
International Forum of Allergy & Rhinology
|
November 25, 2020
International consensus statement on allergy and rhinology: rhinosinusitis 2021
Richard R Orlandi, Todd T Kingdom, Timothy L Smith, et al.
Page
of 44